|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups
|
Luke Timmerman |
12/22/11 |
Seattle
|
|
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech
|
Arlene Weintraub |
10/27/11 |
New York
|
|
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/20/11 |
Seattle
|
|
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question
|
Luke Timmerman |
10/19/11 |
Seattle
|
|
Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine
|
Arlene Weintraub |
10/18/11 |
Boston
|
|
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader
|
Luke Timmerman |
09/13/11 |
Seattle
|
|
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed
|
Luke Timmerman |
07/20/11 |
Seattle
|
|
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig
|
Luke Timmerman |
06/27/11 |
Seattle
|
|
PATH Partners With GSK on Malaria Vaccine
|
Luke Timmerman |
06/06/11 |
Seattle
|
|
From Three-Month Ice to Fast Broadband Everywhere: Some Projects You Might Not Know About From Intellectual Ventures Lab
|
Curt Woodward |
04/21/11 |
Seattle
|
|
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies
|
Luke Timmerman |
03/08/11 |
Seattle
|
|
Pfēnex Awarded $3.1M for Malaria Work
|
Bruce V. Bigelow |
01/26/11 |
San Diego
|
|
Who Will Keep the Flame Alive for Seattle Biotech? Hear From the Players Nov. 29
|
Luke Timmerman |
11/09/10 |
Seattle
|
|
Gates Foundation’s Tachi Yamada: Biotechies and VCs are Missing Out on Global Health
|
Luke Timmerman |
07/30/10 |
Seattle
|
|
How Seattle Startups Could Lead the World: Five Technology Themes to Watch
|
Gregory T. Huang |
06/18/10 |
Seattle
|
|
Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain
|
Ryan McBride |
05/20/10 |
Boston
|
|
Alder’s Long-Awaited Arthritis Data, Ikaria Plots $200M IPO, Emerald’s Resurrection, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/20/10 |
Seattle
|
|
Seattle BioMed Starts Malaria Trial
|
Luke Timmerman |
05/13/10 |
Seattle
|
|
Genocea Gets $2.7M for Malaria Vaccine
|
Luke Timmerman |
04/15/10 |
Boston
|
|
Beaming Power to UAVs, Space Elevators, and Someday, Earth: The LaserMotive Plan
|
Gregory T. Huang |
04/13/10 |
Seattle
|
|
The Dendreon Alumni Directory, Sage Snags Merck Deal, Adaptive TCR Nabs $4.5M & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/01/10 |
Seattle
|
|
Nine Years in the Making, Seattle BioMed’s Malaria Vaccine On Verge of First Human Trial
|
Luke Timmerman |
03/26/10 |
Seattle
|
|
U.S. Chief Humanitarian: We Want to Buy Your Health Products For Poor Countries
|
Luke Timmerman |
03/17/10 |
Seattle
|
|
Una Ryan Searching for Riches to Deliver Inexpensive Diagnostics to the Poor
|
Ryan McBride |
03/05/10 |
Boston
|
|
Bill Gates Posts Annual Letter, Backs Khosla
|
Gregory T. Huang |
01/25/10 |
Seattle
|
|
Genomics Laid the Foundation for Big Global Health Advances To Come This Decade
|
Ken Stuart |
01/21/10 |
Seattle
|
|
The Intellectual Property Century
|
Steve Davis |
01/11/10 |
National
|
|
FDA Approves Over-the-Counter Version of Santarus Drug, Pioneer of Algal Biofuels Says Algae Will Make Drugs Too, Receptos Gets $25M, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
12/02/09 |
San Diego
|
|
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic
|
Luke Timmerman |
11/03/09 |
Seattle
|
|
Vaccine Exec Named SBRI Chair
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.